171 related articles for article (PubMed ID: 29075881)
1. A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice.
Xu X; Li J; Wu J; Zhu R; Ji W
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):206-217. PubMed ID: 29075881
[TBL] [Abstract][Full Text] [Related]
2. The use of ¹²⁵I seed strands for intraluminal brachytherapy of malignant obstructive jaundice.
Chen Y; Wang XL; Yan ZP; Wang JH; Cheng JM; Gong GQ; Luo JJ
Cancer Biother Radiopharm; 2012 Jun; 27(5):317-23. PubMed ID: 21902546
[TBL] [Abstract][Full Text] [Related]
3. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice.
Chen Y; Wang XL; Yan ZP; Cheng JM; Wang JH; Gong GQ; Qian S; Luo JJ; Liu QX
World J Gastroenterol; 2004 Dec; 10(23):3506-10. PubMed ID: 15526374
[TBL] [Abstract][Full Text] [Related]
4. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
5. Damage to pig bile duct caused by intraluminal brachytherapy using a (125)I ribbon.
Chen Y; Wang XL; Yan ZP; Wang JH; Cheng JM; Gong GQ; Li GP
Acta Radiol; 2013 Apr; 54(3):272-7. PubMed ID: 23446746
[TBL] [Abstract][Full Text] [Related]
6. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous biliary stent combined with brachytherapy using
Chen WY; Kong CL; Meng MM; Chen WQ; Zheng LY; Mao JT; Fang SJ; Chen L; Shu GF; Yang Y; Weng QY; Chen MJ; Xu M; Ji JS
World J Clin Cases; 2021 Dec; 9(35):10979-10993. PubMed ID: 35047608
[TBL] [Abstract][Full Text] [Related]
8. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
Montemaggi P; Morganti AG; Dobelbower RR; Brizi G; Smaniotto D; Costamagna G; Cellini N; Marano P
Radiology; 1996 Jun; 199(3):861-6. PubMed ID: 8638018
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma.
Taggar AS; Mann P; Folkert MR; Aliakbari S; Myrehaug SD; Dawson LA
Radiother Oncol; 2021 Dec; 165():60-74. PubMed ID: 34695521
[TBL] [Abstract][Full Text] [Related]
10. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.
Montemaggi P; Costamagna G; Dobelbower RR; Cellini N; Morganti AG; Mutignani M; Perri V; Brizi G; Marano P
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):437-43. PubMed ID: 7538501
[TBL] [Abstract][Full Text] [Related]
11. Preliminary application of brachytherapy with double-strand
Li ZM; Jiao DC; Han XW; Lei QY; Zhou XL; Xu M
Surg Endosc; 2022 Jul; 36(7):4932-4938. PubMed ID: 34845555
[TBL] [Abstract][Full Text] [Related]
12. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.
Autorino R; Bisiello S; Pappalardi B; Privitera V; Buwenge M; Piccolo F; Masciocchi C; Tagliaferri L; Macchia G; Curti CD; Luppatteli M; Cerrotta A; Morganti AG; Valentini V; Mattiucci G
Anticancer Res; 2020 Jun; 40(6):3417-3421. PubMed ID: 32487639
[TBL] [Abstract][Full Text] [Related]
13. Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report.
Macchia G; Costamagna G; Morganti AG; Mutignani M; Giuliante F; Clemente G; Deodato F; Smaniotto D; Mattiucci GC; Sallustio G; Valentini V; Nuzzo G; Cellini N
Dig Liver Dis; 2005 Aug; 37(8):615-8. PubMed ID: 15890567
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of intraluminal brachytherapy using
Yang M; Yan Z; Luo J; Liu Q; Zhang W; Ma J; Zhang Z; Yu T; Zhao Q; Liu L
Brachytherapy; 2016; 15(6):859-864. PubMed ID: 27364870
[TBL] [Abstract][Full Text] [Related]
15. Effect of PTCD-based biliary stent placement combined with 125I particle intracavitary irradiation in treating pancreatic head cancer.
Cao J; Wang Z; Cai H; Zhang J; Yue Y; Liu X; Zhang D
J BUON; 2020; 25(2):1056-1062. PubMed ID: 32521906
[TBL] [Abstract][Full Text] [Related]
16. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG
Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935
[TBL] [Abstract][Full Text] [Related]
17. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies--the question of long-term palliation.
Bruha R; Petrtyl J; Kubecova M; Marecek Z; Dufek V; Urbanek P; Kodadova J; Chodounsky Z
Hepatogastroenterology; 2001; 48(39):631-7. PubMed ID: 11462891
[TBL] [Abstract][Full Text] [Related]
18. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas.
Dvorák J; Jandík P; Melichar B; Jon B; Mergancová J; Zoul Z; Vacek Z; Petera J
Hepatogastroenterology; 2002; 49(46):916-7. PubMed ID: 12143240
[TBL] [Abstract][Full Text] [Related]
19. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G
Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409
[TBL] [Abstract][Full Text] [Related]
20. Intraluminal radiation therapy in the management of malignant biliary obstruction.
Molt P; Hopfan S; Watson RC; Botet JF; Brennan MF
Cancer; 1986 Feb; 57(3):536-44. PubMed ID: 3942986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
